Table 11: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Glargine U-100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* Study G: TRESIBA Administered at the Same Time Each Day or Any Time Each Day as an Add-on to One and up to Three of the Following Oral Agents: Metformin, Sulfonylurea or Glinides or Pioglitazone in Adult Patients The efficacy of TRESIBA was evaluated in a 26-week randomized, open-label, multicenter trial in 687 patients with type 2 diabetes mellitus inadequately controlled on basal insulin alone, oral antidiabetic agents (OADs) alone or both basal insulin and OAD
the raw materials (or culture medium) are other synthesized chemical ingredients
as such, the power of the statistical analyses may not have been robust and the generalizability of the results should be interpreted with caution
Among patients with acute MI undergoing percutaneous interventions, GLP-1 treatment can reduce infarct size, together with improving left ventricular ejection fraction (LVEF) [71]
Its formulated with 86% Galactomyces ferment filtrate, plus glutathione, vitamin C derivatives, rice ceramides / rice extracts, and hyaluronic acid to deeply moisturise, improve skin texture, even out skin tone, and give a healthy, radian
